How will Medicare reimburse the screening test for cervical cancer with human papillomavirus (HPV) when reported with G0476?
Claims with dates of service from July 9, 2015 through December 31, 2016 will be priced by Medicare administrative contractors. Beneficiary coinsurance and deductibles will not be applied to claim lines containing the following code:
G0476 Infectious agent detection by nucleic acid (DNA or RNA); human papillomavirus (HPV), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test
Beginning January 1, 2017, the code will be priced and paid according to the Clinical Laboratory Fee Schedule (CLFS).